Study findings updated . AI-assisted evidence summary, not individual medical advice or a clinician endorsement.
THE SHORT VERSION
What’s worth knowing.
The key findings, what they mean, and the context that matters.
THE HEADLINE TAKEAWAY1.87 years lostDrop in US life expectancy, 2019 to 2020, vs 0.58 years on average in 21 peer nations
US life expectancy fell far more in 2020 than in peer nations.
Using official death counts, researchers found US life expectancy at birth fell 1.87 years from 2019 to 2020. Across 21 other high-income countries the average drop was 0.58 years, and none fell as far as the US. Hispanic Americans lost 3.70 years and Black Americans 3.22 years, far more than White Americans.
Life expectancy sums up a whole population's health in one number. The 2020 drop widened an existing gap between the US and other rich countries, and it fell hardest on Hispanic and Black communities. This covers only 2020; later federal data show US life expectancy has since rebounded above its pre-pandemic level.
See the evidence
A cross-sectional analysis of official 2019 and 2020 death and population counts for the US and 21 other high-income countries.
From the study: “Between 2019 and 2020, US life expectancy decreased by a mean of 1.87 years (CR, 1.70-2.03 years)”
1.87 years lost
Woolf SH et al. Changes in Life Expectancy Between 2019 and 2020 in the US and 21 Peer Countries. JAMA network open. 2022.
From the study: “with much larger decreases occurring in the Hispanic (3.70 years; CR, 3.53-3.87 years) and non-Hispanic Black (3.22 years; CR, 3.03-3.40 years) populations”
1.87 years lost
Woolf SH et al. Changes in Life Expectancy Between 2019 and 2020 in the US and 21 Peer Countries. JAMA network open. 2022.
About 1 in 336 US children lost a live-in caregiver to COVID-19.
1 in 336 childrenUS children who lost a parent or other live-in caregiver to COVID-19 by May 2022
Researchers matched COVID-19 death counts with national household survey data. They estimate 216,617 US children lived with a parent, grandparent or other caregiver who died of COVID-19 between January 2020 and May 2022, about 1 in every 336 children. Hispanic and Black children lost caregivers at 2.1 times the rate of White children.
Losing a caregiver can shake a child's emotional, social and financial footing for years. Counting these children, and seeing where they are concentrated, is the first step toward reaching them through schools, clinics and communities. These are modeled estimates built from death counts and survey data, not a direct count of bereaved children.
See the evidence
A modeling study combining US COVID-19 death counts through May 2022 with a nationally representative household survey to estimate children's caregiver losses.
From the study: “We estimate that 216,617 U.S. children experienced the death of a caregiver with whom they lived, due to COVID-19 infection, between January 1, 2020, and May 9, 2022.”
1 in 336 children
Treglia D et al. Parental and Other Caregiver Loss Due to COVID-19 in the United States: Prevalence by Race, State, Relationship, and Child Age. Journal of community health. 2023.
From the study: “This corresponds to about 1 out of every 336 children under the age of 18.”
1 in 336 children
Treglia D et al. Parental and Other Caregiver Loss Due to COVID-19 in the United States: Prevalence by Race, State, Relationship, and Child Age. Journal of community health. 2023.
From the study: “Hispanic and Non-Hispanic Black children had rates of caregiver loss 2.1 times those of White children.”
1 in 336 children
Treglia D et al. Parental and Other Caregiver Loss Due to COVID-19 in the United States: Prevalence by Race, State, Relationship, and Child Age. Journal of community health. 2023.
COVID-19 fell to the 10th leading US cause of death in 2023.
10th leading causeCOVID-19's rank among US causes of death in 2023, down from fourth in 2022
Provisional US death certificate data show COVID-19 dropped from the fourth to the 10th leading cause of death between 2022 and 2023. Deaths with COVID-19 listed as a cause fell 68.9%, from 245,614 to 76,446. COVID-19 was the main (underlying) cause of 1.6% of all US deaths in 2023, down from 5.7% in 2022.
COVID-19 is no longer the mass killer of 2020 to 2022, but it still ranked among the 10 leading causes of death and was listed on 76,446 death certificates in a single year. These were provisional 2023 counts that could rise slightly as late death certificates are processed.
See the evidence
A CDC report of provisional national death certificate data covering 3,090,582 US deaths in 2023, compared with final 2022 data.
From the study: “COVID-19, the fourth leading cause of death in 2022 became the 10th leading cause in 2023.”
10th leading cause
Ahmad FB et al. Mortality in the United States - Provisional Data, 2023. MMWR. Morbidity and mortality weekly report. 2024.
COVID-19 hospital stays were linked to higher death risk than flu stays.
1.5× risk of deathHazard ratio for death within 18 months of a COVID-19 vs flu hospital stay
Researchers compared US veterans hospitalized for COVID-19 in 2020 to 2022 with veterans hospitalized for seasonal flu in 2015 to 2019. Over 18 months, the COVID-19 group had a 1.51 hazard ratio for death (roughly 1.5 times the risk), or 8.62 extra deaths per 100 people. COVID-19 was also linked to higher risk of 64 of 94 health problems, in every organ system except the lungs.
Many people now think of COVID-19 as a flu-like illness. For people sick enough to need a hospital, this large study linked COVID-19 to more deaths and more lasting health problems than flu. Veterans are mostly older men, and the flu patients were treated before the pandemic, so differences in era could affect the comparison.
See the evidence
A cohort study using US Department of Veterans Affairs health records of tens of thousands of veterans hospitalized for COVID-19 or flu, followed up to 18 months.
From the study: “Over 18 months of follow-up, compared to seasonal influenza, the COVID-19 group had an increased risk of death (hazard ratio [HR] 1·51 [95% CI 1·45-1·58])”
1.5× risk of death
Xie Y et al. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. The Lancet. Infectious diseases. 2024.
From the study: “corresponding to an excess death rate of 8·62 (95% CI 7·55-9·44) per 100 persons in the COVID-19 group versus the influenza group”
1.5× risk of death
Xie Y et al. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. The Lancet. Infectious diseases. 2024.
From the study: “Comparative analyses of 94 prespecified health outcomes showed that COVID-19 had an increased risk of 68·1% (64 of 94) pre-specified health outcomes”
1.5× risk of death
Xie Y et al. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. The Lancet. Infectious diseases. 2024.
About 1 in 67 US adults reported disabling long COVID.
1 in 67 adultsUS adults whose long COVID significantly limited daily activities, per Census surveys
Census Bureau surveys of 757,580 US adults found 1.5% had current long COVID that significantly limited daily activities, about 1 in 67 adults. Another 4.5% had milder long COVID, for an estimated 15 million adults in all. Its disability burden rivaled Alzheimer's or asthma, yet it received 14% of the NIH research funding that burden would predict.
Long COVID is not rare. Millions of adults report it limiting daily life, about half of the most affected aged 20 to 49, while research funding lags far behind the size of the burden. Long COVID was self-reported in an online survey without medical confirmation, and funding comparisons rely on estimated disability weights.
See the evidence
An analysis of 12 monthly US Census Bureau Household Pulse Surveys from September 2022 to August 2023, compared with NIH funding for 68 other conditions.
From the study: “Among them, 1.5% ( n = 10,401) met our case definition of disabling Long COVID”
1 in 67 adults
Bonuck K et al. Long COVID disability burden in US adults. Communications medicine. 2026.
From the study: “An additional 4.5% ( n = 35,963) had Long COVID with little or no activity limits, yielding an estimated 15 million US adults with Long COVID.”
1 in 67 adults
Bonuck K et al. Long COVID disability burden in US adults. Communications medicine. 2026.
Early US vaccination was linked to 139,393 fewer COVID-19 deaths.
139,393 deaths avertedEstimated US COVID-19 deaths averted by vaccination as of May 9, 2021
Comparing vaccination rates and COVID-19 deaths across US states, researchers estimated the first five months of the vaccine campaign were linked to 139,393 fewer deaths by May 9, 2021. The estimated benefit varied by state, from 11.7 fewer deaths per 10,000 people in New York to 1.1 per 10,000 in Hawaii.
Within months of rollout, vaccination was linked to a large drop in deaths, evidence that matters when health officials plan vaccine campaigns for future outbreaks. This state-level statistical analysis shows an association and cannot fully separate vaccination from other factors that lowered deaths.
See the evidence
A state-by-state statistical analysis of US vaccination rates and COVID-19 deaths during the first five months of vaccine availability, through May 2021.
From the study: “We estimated that by May 9, 2021, the US vaccination campaign was associated with a reduction of 139,393 COVID-19 deaths.”
139,393 deaths averted
Gupta S et al. Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States. Health affairs (Project Hope). 2021.
From the study: “In New York, for example, vaccinations led to an estimated 11.7 fewer COVID-19 deaths per 10,000, whereas Hawaii observed the smallest reduction, with an estimated 1.1 fewer deaths per 10,000.”
139,393 deaths averted
Gupta S et al. Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States. Health affairs (Project Hope). 2021.
Unflagged vaccine-skeptical posts outweighed flagged misinformation in curbing vaccine intentions.
46-fold greater impactOverall effect of unflagged vaccine-skeptical Facebook posts vs flagged misinformation
Researchers combined experiments and machine learning to estimate how 13,206 vaccine-related links affected US Facebook users' plans to get vaccinated. Flagged misinformation was more persuasive per view, but few people saw it. Unflagged stories that encouraged doubt, such as reports of rare deaths after vaccination, were seen far more widely, giving them an estimated 46-fold greater overall impact.
Fact-checking outright falsehoods missed most of the problem. Accurate but misleading stories, such as headlines about rare deaths after a shot, spread widely and were estimated to dampen vaccine intentions more overall. Effects on vaccination intentions were estimated from experiments and models, not measured in real vaccination records.
See the evidence
A study combining lab experiments with 18,725 people, crowdsourcing and machine learning to model vaccine content seen by about 233 million US Facebook users.
From the study: “We estimate that the impact of unflagged content that nonetheless encouraged vaccine skepticism was 46-fold greater than that of misinformation flagged by fact-checkers.”
46-fold greater impact
Allen J et al. Quantifying the impact of misinformation and vaccine-skeptical content on Facebook. Science (New York, N.Y.). 2024.
US overdose deaths hit a monthly record in May 2020.
Overdoses up 57.7%Overdose deaths in May 2020 vs May 2019, the deadliest month on record
Using provisional CDC death records, researchers estimated 9,192 Americans died of drug overdoses in May 2020, the deadliest month on record and 57.7% more than in May 2019. Most states saw large increases, with the biggest in West Virginia, Kentucky and Tennessee.
The pandemic's toll reached beyond the virus itself. The overdose crisis worsened sharply in its first months, and smoothed yearly totals can hide such spikes, so the authors call for closer monthly tracking. Monthly counts were estimated from provisional rolling data, and the study cannot show the pandemic itself caused the rise.
See the evidence
An analysis of provisional CDC death records that estimated monthly US drug overdose deaths for January through July 2020.
From the study: “We found that 9192 (95% PI = 8988, 9397) people died from drug overdose in May 2020-making it the deadliest month on record-representing a 57.7% (95% PI = 54.2%, 61.2%) increase over May 2019.”
Overdoses up 57.7%
Friedman J et al. COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020. American journal of public health. 2021.
From the study: “Most states saw large-magnitude increases, with the highest in West Virginia, Kentucky, and Tennessee.”
Overdoses up 57.7%
Friedman J et al. COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020. American journal of public health. 2021.
Hospital workers’ views of staffing and work-pace safety worsened
From April 2020 to July 2022, hospital workers reported worse views of safety related to staffing and work pace. Higher hospital death rates were linked to negative or neutral views.
The analysis used surveys taken at particular times and separated intensive care from other settings. Workers reported their own views. Other differences could partly explain the link with deaths, so the study cannot show cause and effect.
Study details & original results
Edelstein, Lauren et al.. Hospital Workforce Staffing and Work-Pace Safety Perceptions During the COVID-19 Pandemic: A Cross-Sectional Analysis.. Quality management in health care. 2026.
Average annual decline in hospital workers' staffing and work-pace safety perceptions during April 2020 to July 2022
3.5 percentage-point decline per year
Association between a doubling of overall hospital mortality and negative or neutral staffing and work-pace safety perceptions; SE = 0.02 and P < .01
OR 1.38
Setting-stratified associations between a doubling of mortality and negative or neutral staffing and work-pace safety perceptions; ICU SE = 0.12 and non-ICU SE = 0.02, both P < .01
Depressive symptoms were common among older adults studied in mainland China
A review combined study estimates for adults aged 60 years or older living in the community in mainland China. Depressive symptoms were estimated in 16.6% in 2022 and 22.9% in 2024-2025.
Results varied widely between studies, limiting the combined estimate. Most measured people at one point in time, so they cannot show that the pandemic caused a change. These studies do not establish rates for other countries.
Education, marital status and living alone were linked to depressive symptoms
Less education, not being married and living alone were linked to higher odds of depressive symptoms among older adults in mainland China.
The comparison group is not given here. Most studies looked at people at one point in time, and results varied widely. This limits conclusions about cause and whether the findings apply to other groups.
Study details & original results
Wang, Nili et al.. Persistent socio-demographic inequalities in depression among older adults in China during and after COVID-19: a systematic review and meta-analysis.. Frontiers in public health. 2026.
Pooled prevalence of depressive symptoms among community-dwelling adults aged 60 years or older in mainland China; prevalence estimates had substantial between-study heterogeneity (overall I2 = 99.55%).
22.9% in 2024-2025 95% CI: 18.3%-28.3%
Pooled prevalence of depressive symptoms among community-dwelling adults aged 60 years or older in mainland China; prevalence estimates had substantial between-study heterogeneity (overall I2 = 99.55%).
The review found no clear death-rate difference after intensive-care transfer
No clear difference
The review found no clear death-rate difference among adults in intensive care for COVID-19. It compared patients transferred between hospitals' intensive-care units with patients not transferred.
Both exploratory analyses took other differences into account. Their uncertainty ranges included no difference. This does not prove equal outcomes or show that transfer is safe for an individual.
Study details & original results
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=2); the difference was not statistically significant.
HR 0.71 95% CI: 0.34-1.46
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=3); the difference was not statistically significant.
OR 1.29 95% CI: 0.84-1.98
The reported result does not establish a difference; it does not prove equivalence.
Changes in mental-health symptoms did not clearly differ by sex or gender
No clear difference
The review found no clear difference in symptom changes between women or females and men or males. It covered anxiety, depression and stress from before to during the pandemic.
The uncertainty ranges for all three symptoms included no difference. This compares changes over time, not equal symptom levels. Study weaknesses could distort results: high risk of bias, other limits or wide differences between studies remained.
Study details & original results
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous anxiety symptoms; minimal and not statistically significant (7 cohorts; 6,039 participants; I2 = 68.7%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.09 95% CI: -0.04 to 0.22; 95% PI: -0.27 to 0.45
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous stress symptoms; minimal and not statistically significant (8 cohorts; 2,994 participants; I2 = 0%). High risk of bias or other methodological limitations remained present across the analyses.
SMD difference -0.08 95% CI: -0.16 to 0.01; 95% PI: -0.18 to 0.02
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous depression symptoms; minimal and not statistically significant (12 cohorts; 9,750 participants; I2 = 65.4%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.10 95% CI: -0.00 to 0.20; 95% PI: -0.23 to 0.43
The reported result does not establish a difference; it does not prove equivalence.
2025-2026 COVID-19 Vaccines had hospital and emergency-care estimates
The study reported estimates for 2025-2026 COVID-19 Vaccines against COVID-associated hospital admissions and emergency or urgent-care visits in adults.
For 2025-2026 COVID-19 Vaccines, the comparison group is not given here. Estimates also covered adults aged 65 or older. The outcomes were hospital admissions and emergency or urgent-care visits, not all infections.
Study details & original results
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Vaccine effectiveness against COVID-19-associated hospitalization
55% 95% CI: 41%-66%
Vaccine effectiveness against COVID-19-associated ED/UC encounters
50% 95% CI: 42%-57%
Vaccine effectiveness against hospitalization in adults aged 65+
53% 95% CI: 37%-65%
Vaccine effectiveness against ED/UC encounters in adults aged 65+
The estimate depended on how prolonged grief disorder was defined
During the pandemic, a review reported different estimates of how common prolonged grief disorder was under DSM-5-TR and ICD-11 rules.
This summary does not name which population the percentages describe. The China estimate concerns one studied region, not everyone in China. These are not percentages for all adults.
Study details & original results
Li, Shen et al.. Global prevalence of prolonged grief disorder during the COVID-19 pandemic under standardized diagnostic frameworks: A systematic review and meta-analysis.. Psychological medicine. 2026.
Pooled prevalence of prolonged grief disorder during COVID-19 pandemic
24% 95% CI: 13%-36%
PGD prevalence by diagnostic criteria: DSM-5-TR vs ICD-11
18% vs. 26%
PGD prevalence in China, highest among studied regions
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
WHEN YOU WANT TO GO DEEPERSee all 20 findingsOriginal results, comparisons and study details.
6 of 6 source groupsFindings stay together with their study.
SOURCE 073 findings
Edelstein, Lauren et al.. Hospital Workforce Staffing and Work-Pace Safety Perceptions During the COVID-19 Pandemic: A Cross-Sectional Analysis.. Quality management in health care. 2026.
Setting-stratified associations between a doubling of mortality and negative or neutral staffing and work-pace safety perceptions; ICU SE = 0.12 and non-ICU SE = 0.02, both P < .01
Added
OR 1.40 for ICU vs OR 1.14 for non-ICU settingsSource [7]
SOURCE 065 findings
Wang, Nili et al.. Persistent socio-demographic inequalities in depression among older adults in China during and after COVID-19: a systematic review and meta-analysis.. Frontiers in public health. 2026.
Pooled prevalence of depressive symptoms among community-dwelling adults aged 60 years or older in mainland China; prevalence estimates had substantial between-study heterogeneity (overall I2 = 99.55%).
Pooled prevalence of depressive symptoms among community-dwelling adults aged 60 years or older in mainland China; prevalence estimates had substantial between-study heterogeneity (overall I2 = 99.55%).
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=3); the difference was not statistically significant.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=2); the difference was not statistically significant.
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous anxiety symptoms; minimal and not statistically significant (7 cohorts; 6,039 participants; I2 = 68.7%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
Added
SMD difference 0.0995% CI: -0.04 to 0.22; 95% PI: -0.27 to 0.45Source [3]
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous depression symptoms; minimal and not statistically significant (12 cohorts; 9,750 participants; I2 = 65.4%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
Added
SMD difference 0.1095% CI: -0.00 to 0.20; 95% PI: -0.23 to 0.43Source [3]
All 3 findings from this source
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous stress symptoms; minimal and not statistically significant (8 cohorts; 2,994 participants; I2 = 0%). High risk of bias or other methodological limitations remained present across the analyses.
Added
SMD difference -0.0895% CI: -0.16 to 0.01; 95% PI: -0.18 to 0.02Source [3]
SOURCE 013 findings
Li, Shen et al.. Global prevalence of prolonged grief disorder during the COVID-19 pandemic under standardized diagnostic frameworks: A systematic review and meta-analysis.. Psychological medicine. 2026.
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Browse the 15 original sourcesThe complete bibliography behind this monitor.
[1]
Li, Shen et al.. Global prevalence of prolonged grief disorder during the COVID-19 pandemic under standardized diagnostic frameworks: A systematic review and meta-analysis.. Psychological medicine. 2026.
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Gao, Yumeng et al.. Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.. Human vaccines & immunotherapeutics. 2026.
Wang, Nili et al.. Persistent socio-demographic inequalities in depression among older adults in China during and after COVID-19: a systematic review and meta-analysis.. Frontiers in public health. 2026.
Edelstein, Lauren et al.. Hospital Workforce Staffing and Work-Pace Safety Perceptions During the COVID-19 Pandemic: A Cross-Sectional Analysis.. Quality management in health care. 2026.
Treglia D et al. Parental and Other Caregiver Loss Due to COVID-19 in the United States: Prevalence by Race, State, Relationship, and Child Age. Journal of community health. 2023.
Xie Y et al. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. The Lancet. Infectious diseases. 2024.
Friedman J et al. COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020. American journal of public health. 2021.
Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results. Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed.
Download the findings and bibliography displayed in this page snapshot. Values and confidence intervals remain as reported text; this is not a pooled estimate or a systematic review. Product-label observations and editorial takeaways are excluded.
These findings may omit evidence or contain errors and have not been reviewed by a clinician. A citation or download does not establish source verification. Read the original studies for their methods and limitations.
The October 2026 COVID citation audit found errors in this collection. These downloads may still contain affected findings and bibliography entries. Read the correction record before using them.
“Added” dates record entry into the monitor, not publication or clinical review. A null original acquisition or derivation means its historical record is unknown; a current record or verification has its own observation time. The SHA-256 snapshot identifier binds the downloadable public fields. CSV includes finding rows and bibliography-only source rows; JSON includes both lists. Spreadsheet-sensitive CSV cells begin with an apostrophe for safety; JSON preserves the original text.
For attribution, cite ModernDoc and the page URL, data update date and snapshot identifier in the download. Original studies retain their own rights; this download does not grant a licence to their full text.